Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Related Articles by Review for PubMed (Select 23436915)

1.

Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD.

Jørgensen AP, Ueland T, Sode-Carlsen R, Schreiner T, Rabben KF, Farholt S, Høybye C, Christiansen JS, Bollerslev J.

J Clin Endocrinol Metab. 2013 Apr;98(4):E753-60. doi: 10.1210/jc.2012-3378. Epub 2013 Feb 22.

PMID:
23436915
2.

Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C.

Endocrine. 2012 Apr;41(2):191-9. doi: 10.1007/s12020-011-9560-4. Epub 2011 Nov 12. Review.

PMID:
22081257
3.

What is the value of growth hormone therapy in Prader Willi syndrome?

Bridges N.

Arch Dis Child. 2014 Feb;99(2):166-70. doi: 10.1136/archdischild-2013-303760. Epub 2013 Oct 25. Review.

PMID:
24162007
4.
5.

Somatropin therapy in adults with Prader-Willi syndrome.

Höybye C, Thorén M.

Treat Endocrinol. 2004;3(3):153-60. Review.

PMID:
16026111
6.

Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis.

Barake M, Klibanski A, Tritos NA.

J Clin Endocrinol Metab. 2014 Mar;99(3):852-60. doi: 10.1210/jc.2013-3921. Epub 2014 Jan 1. Review.

PMID:
24423364
7.

GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.

Deal CL, Tony M, Höybye C, Allen DB, Tauber M, Christiansen JS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants.

J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87. doi: 10.1210/jc.2012-3888. Epub 2013 Mar 29. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk